383 related articles for article (PubMed ID: 31912158)
21. SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.
Bahrami A; Lee S; Caradine KD; Raimondi SC; Folpe AL
Cancer Genet; 2014 Sep; 207(9):437-40. PubMed ID: 25312828
[TBL] [Abstract][Full Text] [Related]
22. Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013.
Bourdeaut F; Chi SN; Frühwald MC
Cancer Genet; 2014 Sep; 207(9):346-51. PubMed ID: 25468731
[TBL] [Abstract][Full Text] [Related]
23. SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
Agaimy A; Amin MB; Gill AJ; Popp B; Reis A; Berney DM; Magi-Galluzzi C; Sibony M; Smith SC; Suster S; Trpkov K; Hes O; Hartmann A
Hum Pathol; 2018 Jul; 77():139-146. PubMed ID: 29689242
[TBL] [Abstract][Full Text] [Related]
24. SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy.
Soto-Castillo JJ; Llavata-Marti L; Fort-Culillas R; Andreu-Cobo P; Moreno R; Codony C; García Del Muro X; Alemany R; Piulats JM; Martin-Liberal J
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446319
[TBL] [Abstract][Full Text] [Related]
25. SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.
Middeljans E; Wan X; Jansen PW; Sharma V; Stunnenberg HG; Logie C
PLoS One; 2012; 7(3):e33834. PubMed ID: 22442726
[TBL] [Abstract][Full Text] [Related]
26. Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells.
Darr J; Klochendler A; Isaac S; Geiger T; Eden A
Mol Cancer; 2015 Sep; 14():167. PubMed ID: 26370283
[TBL] [Abstract][Full Text] [Related]
27. [Chromatin remodeling defects and cancer: the SWI/SNF example].
Bourdeaut F; Bièche I
Bull Cancer; 2012 Dec; 99(12):1133-40. PubMed ID: 23222069
[TBL] [Abstract][Full Text] [Related]
28. SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report.
Gerber TS; Agaimy A; Hartmann A; Habekost M; Roth W; Stenzinger A; Schirmacher P; Straub BK
Diagn Pathol; 2021 Jun; 16(1):52. PubMed ID: 34118935
[TBL] [Abstract][Full Text] [Related]
29. Coexistent loss of INI1 and BRG1 expression in a rhabdoid renal cell carcinoma (RCC): implications for a possible role of SWI/SNF complex in the pathogenesis of RCC.
Rao Q; Xia QY; Shen Q; Shi SS; Tu P; Shi QL; Zhou XJ
Int J Clin Exp Pathol; 2014; 7(4):1782-7. PubMed ID: 24817979
[TBL] [Abstract][Full Text] [Related]
30. SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development.
Wei D; Goldfarb D; Song S; Cannon C; Yan F; Sakellariou-Thompson D; Emanuele M; Major MB; Weissman BE; Kuwahara Y
Mol Cancer Res; 2014 Nov; 12(11):1574-85. PubMed ID: 25009291
[TBL] [Abstract][Full Text] [Related]
31. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
[TBL] [Abstract][Full Text] [Related]
32. Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors.
Leruste A; Tosello J; Ramos RN; Tauziède-Espariat A; Brohard S; Han ZY; Beccaria K; Andrianteranagna M; Caudana P; Nikolic J; Chauvin C; Niborski LL; Manriquez V; Richer W; Masliah-Planchon J; Grossetête-Lalami S; Bohec M; Lameiras S; Baulande S; Pouponnot C; Coulomb A; Galmiche L; Surdez D; Servant N; Helft J; Sedlik C; Puget S; Benaroch P; Delattre O; Waterfall JJ; Piaggio E; Bourdeaut F
Cancer Cell; 2019 Dec; 36(6):597-612.e8. PubMed ID: 31708437
[TBL] [Abstract][Full Text] [Related]
33. Early-Stage Induction of SWI/SNF Mutations during Esophageal Squamous Cell Carcinogenesis.
Nakazato H; Takeshima H; Kishino T; Kubo E; Hattori N; Nakajima T; Yamashita S; Igaki H; Tachimori Y; Kuniyoshi Y; Ushijima T
PLoS One; 2016; 11(1):e0147372. PubMed ID: 26812616
[TBL] [Abstract][Full Text] [Related]
34. Biology and Treatment of Rhabdoid Tumor.
Geller JI; Roth JJ; Biegel JA
Crit Rev Oncog; 2015; 20(3-4):199-216. PubMed ID: 26349416
[TBL] [Abstract][Full Text] [Related]
35. The SWI/SNF Complex in Neural Crest Cell Development and Disease.
Fountain DM; Sauka-Spengler T
Annu Rev Genomics Hum Genet; 2023 Aug; 24():203-223. PubMed ID: 37624665
[TBL] [Abstract][Full Text] [Related]
36. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors.
DeCristofaro MF; Betz BL; Wang W; Weissman BE
Oncogene; 1999 Dec; 18(52):7559-65. PubMed ID: 10602515
[TBL] [Abstract][Full Text] [Related]
37. Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway.
Zhou Y; Xu Q; Tao L; Chen Y; Shu Y; Wu Z; Lu C; Shi Y; Bu H
Clin Sci (Lond); 2020 Jun; 134(12):1457-1472. PubMed ID: 32514535
[TBL] [Abstract][Full Text] [Related]
38. Rhabdoid and Undifferentiated Phenotype in Renal Cell Carcinoma: Analysis of 32 Cases Indicating a Distinctive Common Pathway of Dedifferentiation Frequently Associated With SWI/SNF Complex Deficiency.
Agaimy A; Cheng L; Egevad L; Feyerabend B; Hes O; Keck B; Pizzolitto S; Sioletic S; Wullich B; Hartmann A
Am J Surg Pathol; 2017 Feb; 41(2):253-262. PubMed ID: 27984237
[TBL] [Abstract][Full Text] [Related]
39. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features.
Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y
Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490
[TBL] [Abstract][Full Text] [Related]
40. Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.
Gadd S; Sredni ST; Huang CC; Perlman EJ;
Lab Invest; 2010 May; 90(5):724-38. PubMed ID: 20212451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
